Lledo, John Karl E.
HRN: 16-99-50 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/21/2022
CEFUROXIME 1.5GM (VIAL)
10/21/2022
10/27/2022
IV
1.5g
Q8H
Indirect Inguinal Hernia, L
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes